ML18068A037

Capital Cardiology, P.C. (2/28/18) - NRC Form 591M Parts 1 & 3, Inspection Report 03037572/2018001 (DNMS)

ML18068A037
Person / Time
Site:	03037572
Issue date:	02/28/2018
From:	Geoffrey Warren NRC/RGN-III
To:	Kritzman M Capital Cardiology, PC
References
IR 2018001
Download: ML18068A037 (2)

See also: IR 07200201/1980001

Text

NRC FORM 591M PART 1 U.S. NUCLEAR REGULATORY

COMMISSION

(07-2012)

1ocFR2.201

SAFETY INSPECTION

REPORT AND COMPLIANCE

INSPECTION

1. LICENSEE/LOCATION

INSPECTED:

Capital Cardiology, P.C. 1200 E. Michigan Ave. Lansing, Michigan 48912 REPORT NUMBER(S)

2018001 3. DOCKET NUMBER(S)

030-37572

LICENSEE:

2. NRC/REGIONAL

OFFICE Region III U. S. Nuclear Regulatory

Commission

2443 Warrenville

Road, Suite 210 Lisle, IL 60532-4352

4. LICENSE NUMBER(S)

5. DATE(S) OF INSPECTION

21-32677-01

The inspection

was an examination

of the activities

conducted

under your license as they relate to radiation

safety and to compliance

with the Nuclear Regulatory

Commission (NRC) rules and regulations

and the conditions

of your license. The inspection

consisted

of selective

examinations

of procedures

and representative

records, interviews

with personnel, and observations

by the inspector.

The inspection

findings are as follows: Based on the inspection

findings, no violations

were identified.

D 2. Previous violation(s)

closed. D 3. D4. The violations(s), specifically

described

to you by the inspector

as non-cited

violations, are not being cited because they were self-identified, non-repetitive, and corrective

action was or is being taken, and the remaining

criteria in the NRC Enforcement

Policy, to exercise discretiol), were satisfied.

Non-cited

violation(s)

were discussed

involving

the following

requirement(s):

During this inspection, certain of your activities, as described

below and/or attached, were in violation

of NRC requirements

and are being cited in accordance

with NRC Enforcement

Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance

with 10 CFR 19.11. (Violations

and Corrective

Actions) Statement

of Corrective

Actions I hereby state that, within 30 days, the actions described

by me to the Inspector

will be taken to correct the violations

identified.

This statement

of corrective

actions is made in accordance

with the requirements

of 10 CFR 2.201 (corrective

steps already taken, corrective

steps which will be taken, date when full compliance

will be achieved).

I understand

that no further written response to NRC will be required, unless specifically

requested.

TITLE PRINTED NAME SIGNATURE

DATE LICENSEE'S

REPRESENTATIVE

NRC INSPECTOR

Geoffrey Warren, Sr. HP BRANCH CHIEF Aaron Mccraw NRC FORM 591M PART 1 (07-2012)

hV-

NRC FORM 591M PART 3 (07-2012)

10 CFR 2.201 U.S. NUCLEAR REGULATORY

COMMISSION

Docket File Information

SAFETY INSPECTION

REPORT AND COMPLIANCE

INSPECTION

1. LICENSEE/LOCATION

INSPECTED:

Capital Cardiology, P.C. 1200 E. Michigan Ave. Lansing, Michigan

48912 REPORT NUMBER(S)

2018001 3. DOCKET NUMBER(S)

030-37572

6. INSPECTION

PROCEDURES

USED 87130 2. NRG/REGIONAL

OFFICE Region III U. S. Nuclear Regulatory

Commission

2443 Warrenville

Road, Suite 210 Lisle, IL 60532:.4352

4. LICENSE NUMBER(S)

21-32677-01

7. INSPECTION

FOCUS AREAS 03.01 -03.09 5. DATE(S) OF INSPECTION

February 28, 2018 SUPPLEMENTAL

INSPECTION

INFORMATION

1. PROGRAM CODE(S) 02201 2. PRIORITY 5 I{] Main Office Inspection

D Field Office Inspection

D Temporary

Job Site Inspection

3. LICENSEE CONTACT 4. TELEPHONE

NUMBER Michelle Kritzman, M.S., RSO (734) 637-2408 Next Inspection

Date: 02/28/2023

PROGRAM SCOPE This was an unannounced

routine inspection.

The licensee was a cardiology

clinic located in Lansing, Michigan, with authorization

to use byproduct

materials

in 10 CPR 35.200 only. The nuclear medicine department

was staffed with one full-time

nuclear medicine technologist, who typically

administered

120 diagnostic

doses monthly, limited to cardiac stress tests. The department received

unit doses as needed from a licensed nuclear pharmacy.

All waste was either held for decay-in-storage (DIS) or returned to the nuclear pharmacy.

Performance

Observations:

The inspector

observed one diagnostic

administration

of licensed materials, including

dose preparation

and disposal.

The technologist

demonstrated

survey meter and wipe counter QC, dose calibrator

constancy, package receipt surveys and wipes, daily and weekly contamination

surveys, and other procedures.

The inspector

noted no concerns with these activities.

Review of dosimetry

records indicated

no exposures

of regulatory

concern. Interviews

with licensee personnel

indicated

adequate knowledge

of radiation

safety concepts and procedures.

The inspector

performed

independent

and confirmatory

radiation

measurements

which indicated

results consistent

with licensee survey records and postings.

No violations

were identified

during this inspection.

NRG FORM 591M PART 3 (07-2012)